ClinicalTrials.Veeva

Menu

Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status

Completed

Conditions

Sturge - Weber Syndrome (SWS)

Treatments

Other: blood sample tear drop sample

Study type

Observational

Funder types

Other

Identifiers

NCT00610402
20065691

Details and patient eligibility

About

Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life.

Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma.

These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.

Full description

The ocular antibody profile in patients with SWS is unknown.The researchers want to study on blood and tear drop samples from patients with SWS to determine the incidence of ocular antibodies in patients with this syndrome.

Enrollment

57 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female volunteers with SWS of all ages

Exclusion criteria

  • Volunteers without SWS

Trial design

57 participants in 1 patient group

blood sample tear drop sample
Description:
blood sample tear drop sample
Treatment:
Other: blood sample tear drop sample

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems